Earnings season continues Thursday with more results being released. We’re expecting the latest reports from Federated Investors Inc (NYSE:FII), Verisign, Inc. (NASDAQ:VRSN), Zynga Inc (NASDAQ:ZNGA), Theravance Inc (NASDAQ:THRX) and Medifast Inc (NYSE:MED).

Earnings

Earnings Preview

Federated Investors Inc (FII)

Analysts are expecting Federated Investors Inc (NYSE:FII) to report second quarter earnings of 40 cents per share on revenue of $233 million. Full-year earnings are expected to be $1.70 per share on full-year revenue of $977 million.

Three of the company’s last five quarters have been positive surprises, although the second quarter of last year and also the first quarter of this year were slight misses. Analyst estimates for the company have fallen from 44 cents 90 days ago to 40 cents seven days ago.

Verisign, Inc. (VRSN)

Consensus estimates for Verisign, Inc. (NASDAQ:VRSN) indicate expectations that the company will report earnings per share of 55 cents on revenue of $237 million. Full-year earnings are expected to be $2.25 on full-year revenue of $957 million.

Verisign, Inc. (NASDAQ:VRSN) has surprised analysts in the last three quarters, coming out just slightly ahead of consensus. Analysts reporting to Zacks have not changed their estimates for the company in the last 30 days.

Zynga Inc (ZNGA)

Analysts are projecting Zynga Inc (NASDAQ:ZNGA) to report second quarter losses of between 4 and 7 cents on revenue of $224 million. Full-year losses are expected to be between 5 and 17 cents on full-year revenue of $939 million.

Zynga Inc (NASDAQ:ZNGA) recently poached Xbox chief Don Mattrick from Microsoft Corporation (NASDAQ:MSFT) to replace Mark Pincus, and there has been a lot of optimism surrounding that move. In spite of the 17-cent loss Zacks is projecting this year, the firm still rates Zynga as a Strong Buy.

Theravance Inc (THRX)

Analysts believe Theravance Inc (NASDAQ:THRX) will report losses anywhere from 74 cents to 46 cents per share, depending on the reporting company. Full-year losses are projected between $2.64 and $2.06 per share.

Estimates from Zacks indicate an expected loss of 59 cents per share for the second quarter. Analysts at the firm have not changed their estimates for Theravance Inc (NASDAQ:THRX) in the last 60 days.

Medifast Inc (MED)

Analysts are estimating that Medifast Inc (NYSE:MED) will report earnings of 51 cents on revenue of $101 million for the second quarter of the year. Full-year earnings are projected to be $1.80 per share on full-year revenue of $386 million.

Medifast Inc (NYSE:MED) has posted significant surprises in each of the last four quarters. Estimates from analysts reporting to Zacks have not changed in the last 60 days.